atomoxetine hydrochloride (OWP Pharmaceuticals)

N/A

Report date: 2025/10/24 11:30:37

Base Information

Drug Nameatomoxetine hydrochloride (OWP Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporter
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOWP Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOWP Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A